In a 76-year-old woman with hypertension, type 2 diabetes mellitus, stage IV chronic kidney disease, atrial fibrillation on apixaban, presenting with massive hematochezia, hypotension, tachycardia, severe anemia, and elevated lactate after resuscitation, which imaging study should be performed next to identify the source of active lower gastrointestinal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CT Angiography of the Abdomen and Pelvis

In this hemodynamically unstable patient with massive lower GI bleeding, you should order CT angiography (CTA) of the abdomen and pelvis immediately. This is the optimal diagnostic test for actively bleeding patients, even those who are hemodynamically precarious, and will guide definitive management 1.

Rationale for CTA in This Clinical Scenario

This patient presents with the ideal indication for CTA:

  • Active massive bleeding (large volume hematochezia with hemoglobin 7.1)
  • Hemodynamic instability (BP 78/45, HR 124, lactate 4.4) despite resuscitation
  • High-risk features including anticoagulation use (apixaban), advanced CKD stage IV, and elderly age

CTA is specifically designed for this exact clinical situation. The 2024 ACG/SAR consensus guidelines establish that CTA is highly sensitive (85-90%), specific (92%), and accurate (94-95%) for detecting and localizing overt GI bleeding 1. Critically, CTA can be completed within minutes and is explicitly recommended even in hemodynamically unstable patients 1, 2.

Why CTA Over the Alternatives

CT without contrast is inadequate - it cannot identify active bleeding or the vascular source. Single-phase noncontrast CT has no role in acute GI bleeding management 2.

Red blood cell scintigraphy is contraindicated in this patient. The 2024 guidelines explicitly warn against performing RBC scans in hemodynamically unstable patients due to hypotension or abnormal heart rate 1. The long imaging time (potentially hours) is incompatible with this patient's critical condition requiring urgent intervention. Additionally, RBC scans have a 10-33% rate of incorrect localization 1, which would be catastrophic in a patient this unstable.

Technical Approach

The CTA protocol should include 1:

  • Noncontrast phase (or virtual noncontrast if available) - identifies high-attenuation material that could mimic bleeding
  • Late arterial phase (35 seconds) - captures arterial opacification and early contrast extravasation
  • Portal venous phase (60-70 seconds) - allows detection of slower venous bleeding and better organ evaluation

Avoid oral contrast - this delays scanning and obscures bleeding 1, 2.

Clinical Advantages in This Patient

CTA provides multiple benefits critical to this case:

  1. Rapid diagnosis - Can detect bleeding rates as low as 0.1 mL/min with modern multidetector scanners 1
  2. Vascular roadmap - Identifies the specific arterial branch feeding the bleeding site, allowing focused catheter angiography if needed 1, 2
  3. Prognostic information - Extravasation volume correlates with transfusion requirements and need for intervention 1
  4. Identifies etiology - Can detect diverticular bleeding, vascular ectasias, masses, or other causes 1

Next Steps After CTA

If CTA demonstrates active extravasation, this patient will likely require urgent catheter angiography with embolization given her hemodynamic instability and ongoing bleeding despite resuscitation 1. The CTA findings will guide the interventional radiologist to the specific mesenteric vessel territory, reducing procedure time and contrast exposure 1, 2.

If CTA is negative, this actually provides valuable prognostic information - negative CTA is associated with decreased rebleeding rates and reduced need for intervention 1.

Critical Caveat Regarding CKD

While this patient has CKD stage IV (creatinine 2.6), the immediate mortality risk from uncontrolled hemorrhage far outweighs concerns about contrast-induced nephropathy in this hemodynamically unstable scenario. The elevated lactate (4.4) indicates tissue hypoperfusion, and identifying the bleeding source is life-saving. Adequate resuscitation with fluids and blood products provides some renal protection during contrast administration.

Related Questions

In an 81-year-old male with peripheral vascular disease and end-stage renal disease on hemodialysis, is it safe to use rivaroxaban (Xarelto) 2.5 mg twice daily?
Are Eliquis (apixaban) and Xarelto (rivaroxaban) interchangeable for atrial fibrillation (AFib)?
How to manage bleeding risk in a patient with atrial fibrillation or deep vein thrombosis on anti-thrombotic therapy, such as warfarin (Coumadin) or novel oral anticoagulants (NOACs) like apixaban (Eliquis) or rivaroxaban (Xarelto), with a high risk of thrombotic events and a high HAS-BLED score?
Can I live a normal life while taking the blood thinner Eliquis (apixaban)?
In a 73-year-old man with hypertension, diabetes mellitus, early chronic kidney disease (impaired renal function) taking apixaban (Eliquis) 5 mg twice daily and amiodarone (Cardarone) XL 200 mg twice daily who is found to have hypokalemia, what are the appropriate management steps?
In a 45-year-old woman 9 days after allogeneic bone marrow transplantation for non‑Hodgkin lymphoma, who develops rapid dyspnea, orthopnea, hypoxemia, tachycardia, tachypnea, normal blood pressure, afebrile status, bilateral crackles, a minimally productive cough, leukopenia, thrombocytopenia, modestly elevated brain natriuretic peptide, normal troponin I, and diffuse central ground‑glass opacities on chest CT, which of the following is the most likely diagnosis: cardiogenic pulmonary edema, diffuse alveolar hemorrhage, fungal pneumonia, or cytomegalovirus pneumonia?
In a 32‑year‑old man with ankylosing spondylitis on naproxen who still has morning back stiffness, limited spinal range of motion, sacroiliac tenderness, and mildly elevated inflammatory markers, does referral to physical therapy aid management?
How should amoebiasis be managed after a patient has completed one week of metronidazole therapy?
What is the appropriate emergency department management for posterior reversible encephalopathy syndrome (PRES)?
In a 75-year-old male with a mechanical aortic valve replacement on warfarin (target INR 2.5–3.5), hypertension, and dyslipidemia, should I proceed with elective cystoscopy while maintaining therapeutic anticoagulation, or is bridging or holding warfarin required?
What is the recommended medical management for acute cholecystitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.